From the Center for Health Journalism: President Trump’s plans to speed up the process of FDA drug approvals, in combination with the increase of off-label marketing from pharmaceutical companies, may decrease the safety of FDA approved drugs.
Support MIA
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.